nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP3A4—Thiotepa—sarcoma	0.0897	0.458	CbGbCtD
Glipizide—CYP3A4—Mitoxantrone—sarcoma	0.0385	0.197	CbGbCtD
Glipizide—PPARG—dermis—sarcoma	0.0379	0.121	CbGeAlD
Glipizide—PPARG—periosteum—sarcoma	0.0314	0.1	CbGeAlD
Glipizide—CYP3A4—Vincristine—sarcoma	0.0265	0.136	CbGbCtD
Glipizide—PPARG—leg—sarcoma	0.025	0.0798	CbGeAlD
Glipizide—PPARG—forelimb—sarcoma	0.0248	0.0792	CbGeAlD
Glipizide—CYP3A4—Etoposide—sarcoma	0.0243	0.124	CbGbCtD
Glipizide—PPARG—hindlimb—sarcoma	0.0223	0.0712	CbGeAlD
Glipizide—PPARG—appendage—sarcoma	0.0191	0.0611	CbGeAlD
Glipizide—CYP3A4—Doxorubicin—sarcoma	0.0166	0.0847	CbGbCtD
Glipizide—PPARG—Teniposide—Etoposide—sarcoma	0.0154	1	CbGdCrCtD
Glipizide—KCNJ11—mammary gland—sarcoma	0.0133	0.0423	CbGeAlD
Glipizide—ABCC8—mammary gland—sarcoma	0.0122	0.0389	CbGeAlD
Glipizide—PPARG—endothelium—sarcoma	0.0116	0.0369	CbGeAlD
Glipizide—Gliclazide—VEGFA—sarcoma	0.0109	1	CrCbGaD
Glipizide—PPARG—mammary gland—sarcoma	0.00932	0.0297	CbGeAlD
Glipizide—KCNJ11—hematopoietic system—sarcoma	0.00807	0.0258	CbGeAlD
Glipizide—ABCC8—seminal vesicle—sarcoma	0.00782	0.025	CbGeAlD
Glipizide—ABCC8—smooth muscle tissue—sarcoma	0.00655	0.0209	CbGeAlD
Glipizide—PPARG—embryo—sarcoma	0.00636	0.0203	CbGeAlD
Glipizide—KCNJ11—lymphoid tissue—sarcoma	0.00568	0.0181	CbGeAlD
Glipizide—PPARG—hematopoietic system—sarcoma	0.00568	0.0181	CbGeAlD
Glipizide—PPARG—connective tissue—sarcoma	0.00547	0.0174	CbGeAlD
Glipizide—CYP2C9—mammary gland—sarcoma	0.00546	0.0174	CbGeAlD
Glipizide—KCNJ11—tendon—sarcoma	0.00534	0.017	CbGeAlD
Glipizide—PPARG—smooth muscle tissue—sarcoma	0.005	0.016	CbGeAlD
Glipizide—PPARG—skin of body—sarcoma	0.00493	0.0157	CbGeAlD
Glipizide—PPARG—uterus—sarcoma	0.00429	0.0137	CbGeAlD
Glipizide—ABCC8—testis—sarcoma	0.00407	0.013	CbGeAlD
Glipizide—PPARG—lymphoid tissue—sarcoma	0.004	0.0128	CbGeAlD
Glipizide—PPARG—tendon—sarcoma	0.00376	0.012	CbGeAlD
Glipizide—PPARG—bone marrow—sarcoma	0.00364	0.0116	CbGeAlD
Glipizide—CYP2C9—hematopoietic system—sarcoma	0.00332	0.0106	CbGeAlD
Glipizide—KCNJ11—lymph node—sarcoma	0.00321	0.0102	CbGeAlD
Glipizide—PPARG—testis—sarcoma	0.00311	0.00993	CbGeAlD
Glipizide—PPARG—liver—sarcoma	0.00294	0.00938	CbGeAlD
Glipizide—CYP3A4—hematopoietic system—sarcoma	0.00253	0.00809	CbGeAlD
Glipizide—PPARG—lymph node—sarcoma	0.00225	0.00719	CbGeAlD
Glipizide—CYP2C9—liver—sarcoma	0.00172	0.0055	CbGeAlD
Glipizide—Hepatic function abnormal—Doxorubicin—sarcoma	0.00139	0.00298	CcSEcCtD
Glipizide—Oedema—Mitoxantrone—sarcoma	0.00138	0.00297	CcSEcCtD
Glipizide—Gastrointestinal disorder—Thiotepa—sarcoma	0.00138	0.00297	CcSEcCtD
Glipizide—Decreased appetite—Dactinomycin—sarcoma	0.00138	0.00297	CcSEcCtD
Glipizide—Hyperhidrosis—Vincristine—sarcoma	0.00137	0.00295	CcSEcCtD
Glipizide—Constipation—Thiotepa—sarcoma	0.00137	0.00294	CcSEcCtD
Glipizide—Pain—Thiotepa—sarcoma	0.00137	0.00294	CcSEcCtD
Glipizide—Shock—Mitoxantrone—sarcoma	0.00136	0.00292	CcSEcCtD
Glipizide—Pain—Dactinomycin—sarcoma	0.00136	0.00292	CcSEcCtD
Glipizide—Muscle spasms—Etoposide—sarcoma	0.00135	0.00291	CcSEcCtD
Glipizide—Thrombocytopenia—Mitoxantrone—sarcoma	0.00135	0.00291	CcSEcCtD
Glipizide—Anorexia—Vincristine—sarcoma	0.00135	0.00291	CcSEcCtD
Glipizide—Eczema—Doxorubicin—sarcoma	0.00135	0.0029	CcSEcCtD
Glipizide—Hypoglycaemia—Epirubicin—sarcoma	0.00134	0.00289	CcSEcCtD
Glipizide—Hyperhidrosis—Mitoxantrone—sarcoma	0.00133	0.00287	CcSEcCtD
Glipizide—Feeling abnormal—Thiotepa—sarcoma	0.00132	0.00283	CcSEcCtD
Glipizide—Anorexia—Mitoxantrone—sarcoma	0.00132	0.00283	CcSEcCtD
Glipizide—Hyponatraemia—Epirubicin—sarcoma	0.00131	0.00283	CcSEcCtD
Glipizide—CYP3A4—liver—sarcoma	0.00131	0.00419	CbGeAlD
Glipizide—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.00131	0.00282	CcSEcCtD
Glipizide—Diplopia—Epirubicin—sarcoma	0.00131	0.00282	CcSEcCtD
Glipizide—Feeling abnormal—Dactinomycin—sarcoma	0.00131	0.00281	CcSEcCtD
Glipizide—Gastrointestinal pain—Thiotepa—sarcoma	0.00131	0.00281	CcSEcCtD
Glipizide—Ill-defined disorder—Etoposide—sarcoma	0.0013	0.00281	CcSEcCtD
Glipizide—Gastrointestinal pain—Dactinomycin—sarcoma	0.0013	0.00279	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Vincristine—sarcoma	0.00129	0.00278	CcSEcCtD
Glipizide—Migraine—Epirubicin—sarcoma	0.00129	0.00277	CcSEcCtD
Glipizide—Insomnia—Vincristine—sarcoma	0.00128	0.00276	CcSEcCtD
Glipizide—Paraesthesia—Vincristine—sarcoma	0.00127	0.00274	CcSEcCtD
Glipizide—Urticaria—Thiotepa—sarcoma	0.00127	0.00273	CcSEcCtD
Glipizide—Malaise—Etoposide—sarcoma	0.00127	0.00273	CcSEcCtD
Glipizide—Vertigo—Etoposide—sarcoma	0.00126	0.00272	CcSEcCtD
Glipizide—Abdominal pain—Thiotepa—sarcoma	0.00126	0.00272	CcSEcCtD
Glipizide—Leukopenia—Etoposide—sarcoma	0.00126	0.00271	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00126	0.00271	CcSEcCtD
Glipizide—Abdominal pain—Dactinomycin—sarcoma	0.00125	0.0027	CcSEcCtD
Glipizide—Hypoglycaemia—Doxorubicin—sarcoma	0.00124	0.00267	CcSEcCtD
Glipizide—Paraesthesia—Mitoxantrone—sarcoma	0.00124	0.00267	CcSEcCtD
Glipizide—Loss of consciousness—Etoposide—sarcoma	0.00124	0.00266	CcSEcCtD
Glipizide—Decreased appetite—Vincristine—sarcoma	0.00123	0.00265	CcSEcCtD
Glipizide—Dyspnoea—Mitoxantrone—sarcoma	0.00123	0.00265	CcSEcCtD
Glipizide—Somnolence—Mitoxantrone—sarcoma	0.00123	0.00264	CcSEcCtD
Glipizide—Gastrointestinal disorder—Vincristine—sarcoma	0.00122	0.00263	CcSEcCtD
Glipizide—Hyponatraemia—Doxorubicin—sarcoma	0.00122	0.00262	CcSEcCtD
Glipizide—Dyspepsia—Mitoxantrone—sarcoma	0.00121	0.00261	CcSEcCtD
Glipizide—Hypertension—Etoposide—sarcoma	0.00121	0.00261	CcSEcCtD
Glipizide—Pain—Vincristine—sarcoma	0.00121	0.00261	CcSEcCtD
Glipizide—Constipation—Vincristine—sarcoma	0.00121	0.00261	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.00121	0.00261	CcSEcCtD
Glipizide—Diplopia—Doxorubicin—sarcoma	0.00121	0.00261	CcSEcCtD
Glipizide—Decreased appetite—Mitoxantrone—sarcoma	0.0012	0.00258	CcSEcCtD
Glipizide—Abdominal pain upper—Epirubicin—sarcoma	0.0012	0.00257	CcSEcCtD
Glipizide—Migraine—Doxorubicin—sarcoma	0.00119	0.00257	CcSEcCtD
Glipizide—Discomfort—Etoposide—sarcoma	0.00118	0.00255	CcSEcCtD
Glipizide—Pain—Mitoxantrone—sarcoma	0.00118	0.00254	CcSEcCtD
Glipizide—Constipation—Mitoxantrone—sarcoma	0.00118	0.00254	CcSEcCtD
Glipizide—Hypersensitivity—Thiotepa—sarcoma	0.00118	0.00253	CcSEcCtD
Glipizide—Hypersensitivity—Dactinomycin—sarcoma	0.00117	0.00251	CcSEcCtD
Glipizide—Gastrointestinal pain—Vincristine—sarcoma	0.00116	0.00249	CcSEcCtD
Glipizide—Confusional state—Etoposide—sarcoma	0.00116	0.00249	CcSEcCtD
Glipizide—Asthenia—Thiotepa—sarcoma	0.00115	0.00247	CcSEcCtD
Glipizide—Asthenia—Dactinomycin—sarcoma	0.00114	0.00245	CcSEcCtD
Glipizide—Feeling abnormal—Mitoxantrone—sarcoma	0.00114	0.00245	CcSEcCtD
Glipizide—Pruritus—Thiotepa—sarcoma	0.00113	0.00243	CcSEcCtD
Glipizide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00113	0.00243	CcSEcCtD
Glipizide—Thrombocytopenia—Etoposide—sarcoma	0.00112	0.00242	CcSEcCtD
Glipizide—Abdominal pain—Vincristine—sarcoma	0.00112	0.00241	CcSEcCtD
Glipizide—Hyperhidrosis—Etoposide—sarcoma	0.00111	0.00239	CcSEcCtD
Glipizide—Abdominal pain upper—Doxorubicin—sarcoma	0.00111	0.00238	CcSEcCtD
Glipizide—Urticaria—Mitoxantrone—sarcoma	0.0011	0.00236	CcSEcCtD
Glipizide—Anorexia—Etoposide—sarcoma	0.00109	0.00235	CcSEcCtD
Glipizide—Diarrhoea—Thiotepa—sarcoma	0.00109	0.00235	CcSEcCtD
Glipizide—Abdominal pain—Mitoxantrone—sarcoma	0.00109	0.00235	CcSEcCtD
Glipizide—Diarrhoea—Dactinomycin—sarcoma	0.00108	0.00233	CcSEcCtD
Glipizide—Pancytopenia—Epirubicin—sarcoma	0.00107	0.00231	CcSEcCtD
Glipizide—Dysuria—Epirubicin—sarcoma	0.00106	0.00228	CcSEcCtD
Glipizide—Dizziness—Thiotepa—sarcoma	0.00106	0.00227	CcSEcCtD
Glipizide—Hypersensitivity—Vincristine—sarcoma	0.00104	0.00225	CcSEcCtD
Glipizide—Photosensitivity reaction—Epirubicin—sarcoma	0.00103	0.00222	CcSEcCtD
Glipizide—Paraesthesia—Etoposide—sarcoma	0.00103	0.00222	CcSEcCtD
Glipizide—Dyspnoea—Etoposide—sarcoma	0.00102	0.0022	CcSEcCtD
Glipizide—Somnolence—Etoposide—sarcoma	0.00102	0.0022	CcSEcCtD
Glipizide—Hypersensitivity—Mitoxantrone—sarcoma	0.00102	0.00219	CcSEcCtD
Glipizide—Asthenia—Vincristine—sarcoma	0.00102	0.00219	CcSEcCtD
Glipizide—Vomiting—Thiotepa—sarcoma	0.00102	0.00219	CcSEcCtD
Glipizide—Drowsiness—Epirubicin—sarcoma	0.00101	0.00217	CcSEcCtD
Glipizide—Vomiting—Dactinomycin—sarcoma	0.00101	0.00217	CcSEcCtD
Glipizide—Rash—Thiotepa—sarcoma	0.00101	0.00217	CcSEcCtD
Glipizide—Dermatitis—Thiotepa—sarcoma	0.00101	0.00217	CcSEcCtD
Glipizide—Headache—Thiotepa—sarcoma	0.001	0.00215	CcSEcCtD
Glipizide—Rash—Dactinomycin—sarcoma	0.001	0.00215	CcSEcCtD
Glipizide—Decreased appetite—Etoposide—sarcoma	0.000998	0.00215	CcSEcCtD
Glipizide—Pancytopenia—Doxorubicin—sarcoma	0.000994	0.00214	CcSEcCtD
Glipizide—Gastrointestinal disorder—Etoposide—sarcoma	0.000991	0.00213	CcSEcCtD
Glipizide—Asthenia—Mitoxantrone—sarcoma	0.00099	0.00213	CcSEcCtD
Glipizide—Jaundice—Epirubicin—sarcoma	0.000983	0.00212	CcSEcCtD
Glipizide—Pain—Etoposide—sarcoma	0.000981	0.00211	CcSEcCtD
Glipizide—Constipation—Etoposide—sarcoma	0.000981	0.00211	CcSEcCtD
Glipizide—Conjunctivitis—Epirubicin—sarcoma	0.00098	0.00211	CcSEcCtD
Glipizide—Dysuria—Doxorubicin—sarcoma	0.000979	0.00211	CcSEcCtD
Glipizide—Diarrhoea—Vincristine—sarcoma	0.000969	0.00209	CcSEcCtD
Glipizide—Sweating—Epirubicin—sarcoma	0.000967	0.00208	CcSEcCtD
Glipizide—Photosensitivity reaction—Doxorubicin—sarcoma	0.000955	0.00206	CcSEcCtD
Glipizide—Hepatobiliary disease—Epirubicin—sarcoma	0.000954	0.00205	CcSEcCtD
Glipizide—Nausea—Thiotepa—sarcoma	0.000949	0.00204	CcSEcCtD
Glipizide—Feeling abnormal—Etoposide—sarcoma	0.000946	0.00204	CcSEcCtD
Glipizide—Diarrhoea—Mitoxantrone—sarcoma	0.000944	0.00203	CcSEcCtD
Glipizide—Nausea—Dactinomycin—sarcoma	0.000942	0.00203	CcSEcCtD
Glipizide—Agranulocytosis—Epirubicin—sarcoma	0.000941	0.00203	CcSEcCtD
Glipizide—Gastrointestinal pain—Etoposide—sarcoma	0.000938	0.00202	CcSEcCtD
Glipizide—Dizziness—Vincristine—sarcoma	0.000937	0.00202	CcSEcCtD
Glipizide—Drowsiness—Doxorubicin—sarcoma	0.000933	0.00201	CcSEcCtD
Glipizide—Urticaria—Etoposide—sarcoma	0.000912	0.00196	CcSEcCtD
Glipizide—Jaundice—Doxorubicin—sarcoma	0.00091	0.00196	CcSEcCtD
Glipizide—Rhinitis—Epirubicin—sarcoma	0.000908	0.00195	CcSEcCtD
Glipizide—Abdominal pain—Etoposide—sarcoma	0.000907	0.00195	CcSEcCtD
Glipizide—Conjunctivitis—Doxorubicin—sarcoma	0.000907	0.00195	CcSEcCtD
Glipizide—Hepatitis—Epirubicin—sarcoma	0.000906	0.00195	CcSEcCtD
Glipizide—Hypoaesthesia—Epirubicin—sarcoma	0.000901	0.00194	CcSEcCtD
Glipizide—Vomiting—Vincristine—sarcoma	0.000901	0.00194	CcSEcCtD
Glipizide—Pharyngitis—Epirubicin—sarcoma	0.000899	0.00193	CcSEcCtD
Glipizide—Sweating—Doxorubicin—sarcoma	0.000895	0.00193	CcSEcCtD
Glipizide—Rash—Vincristine—sarcoma	0.000893	0.00192	CcSEcCtD
Glipizide—Dermatitis—Vincristine—sarcoma	0.000892	0.00192	CcSEcCtD
Glipizide—Headache—Vincristine—sarcoma	0.000888	0.00191	CcSEcCtD
Glipizide—Hepatobiliary disease—Doxorubicin—sarcoma	0.000883	0.0019	CcSEcCtD
Glipizide—Vomiting—Mitoxantrone—sarcoma	0.000877	0.00189	CcSEcCtD
Glipizide—Visual impairment—Epirubicin—sarcoma	0.000873	0.00188	CcSEcCtD
Glipizide—Agranulocytosis—Doxorubicin—sarcoma	0.000871	0.00187	CcSEcCtD
Glipizide—Rash—Mitoxantrone—sarcoma	0.00087	0.00187	CcSEcCtD
Glipizide—Dermatitis—Mitoxantrone—sarcoma	0.000869	0.00187	CcSEcCtD
Glipizide—Headache—Mitoxantrone—sarcoma	0.000864	0.00186	CcSEcCtD
Glipizide—Eye disorder—Epirubicin—sarcoma	0.000846	0.00182	CcSEcCtD
Glipizide—Hypersensitivity—Etoposide—sarcoma	0.000846	0.00182	CcSEcCtD
Glipizide—Nausea—Vincristine—sarcoma	0.000842	0.00181	CcSEcCtD
Glipizide—Flushing—Epirubicin—sarcoma	0.00084	0.00181	CcSEcCtD
Glipizide—Rhinitis—Doxorubicin—sarcoma	0.00084	0.00181	CcSEcCtD
Glipizide—Hepatitis—Doxorubicin—sarcoma	0.000838	0.0018	CcSEcCtD
Glipizide—Hypoaesthesia—Doxorubicin—sarcoma	0.000834	0.00179	CcSEcCtD
Glipizide—Pharyngitis—Doxorubicin—sarcoma	0.000832	0.00179	CcSEcCtD
Glipizide—Asthenia—Etoposide—sarcoma	0.000823	0.00177	CcSEcCtD
Glipizide—Nausea—Mitoxantrone—sarcoma	0.00082	0.00176	CcSEcCtD
Glipizide—Chills—Epirubicin—sarcoma	0.000812	0.00175	CcSEcCtD
Glipizide—Pruritus—Etoposide—sarcoma	0.000812	0.00175	CcSEcCtD
Glipizide—Arrhythmia—Epirubicin—sarcoma	0.000809	0.00174	CcSEcCtD
Glipizide—Visual impairment—Doxorubicin—sarcoma	0.000807	0.00174	CcSEcCtD
Glipizide—Erythema—Epirubicin—sarcoma	0.000788	0.0017	CcSEcCtD
Glipizide—Diarrhoea—Etoposide—sarcoma	0.000785	0.00169	CcSEcCtD
Glipizide—Eye disorder—Doxorubicin—sarcoma	0.000783	0.00168	CcSEcCtD
Glipizide—Flushing—Doxorubicin—sarcoma	0.000778	0.00167	CcSEcCtD
Glipizide—Flatulence—Epirubicin—sarcoma	0.000777	0.00167	CcSEcCtD
Glipizide—Tension—Epirubicin—sarcoma	0.000774	0.00166	CcSEcCtD
Glipizide—Nervousness—Epirubicin—sarcoma	0.000766	0.00165	CcSEcCtD
Glipizide—Dizziness—Etoposide—sarcoma	0.000759	0.00163	CcSEcCtD
Glipizide—Muscle spasms—Epirubicin—sarcoma	0.000758	0.00163	CcSEcCtD
Glipizide—Chills—Doxorubicin—sarcoma	0.000752	0.00162	CcSEcCtD
Glipizide—Arrhythmia—Doxorubicin—sarcoma	0.000748	0.00161	CcSEcCtD
Glipizide—Vision blurred—Epirubicin—sarcoma	0.000743	0.0016	CcSEcCtD
Glipizide—Ill-defined disorder—Epirubicin—sarcoma	0.000731	0.00157	CcSEcCtD
Glipizide—Vomiting—Etoposide—sarcoma	0.00073	0.00157	CcSEcCtD
Glipizide—Erythema—Doxorubicin—sarcoma	0.000729	0.00157	CcSEcCtD
Glipizide—Rash—Etoposide—sarcoma	0.000724	0.00156	CcSEcCtD
Glipizide—Dermatitis—Etoposide—sarcoma	0.000723	0.00156	CcSEcCtD
Glipizide—Headache—Etoposide—sarcoma	0.000719	0.00155	CcSEcCtD
Glipizide—Flatulence—Doxorubicin—sarcoma	0.000719	0.00155	CcSEcCtD
Glipizide—Tension—Doxorubicin—sarcoma	0.000716	0.00154	CcSEcCtD
Glipizide—Malaise—Epirubicin—sarcoma	0.000711	0.00153	CcSEcCtD
Glipizide—Nervousness—Doxorubicin—sarcoma	0.000708	0.00152	CcSEcCtD
Glipizide—Vertigo—Epirubicin—sarcoma	0.000708	0.00152	CcSEcCtD
Glipizide—Syncope—Epirubicin—sarcoma	0.000707	0.00152	CcSEcCtD
Glipizide—Leukopenia—Epirubicin—sarcoma	0.000706	0.00152	CcSEcCtD
Glipizide—Muscle spasms—Doxorubicin—sarcoma	0.000701	0.00151	CcSEcCtD
Glipizide—Loss of consciousness—Epirubicin—sarcoma	0.000693	0.00149	CcSEcCtD
Glipizide—Vision blurred—Doxorubicin—sarcoma	0.000687	0.00148	CcSEcCtD
Glipizide—Nausea—Etoposide—sarcoma	0.000682	0.00147	CcSEcCtD
Glipizide—Hypertension—Epirubicin—sarcoma	0.000681	0.00146	CcSEcCtD
Glipizide—Ill-defined disorder—Doxorubicin—sarcoma	0.000677	0.00146	CcSEcCtD
Glipizide—Myalgia—Epirubicin—sarcoma	0.000671	0.00144	CcSEcCtD
Glipizide—Arthralgia—Epirubicin—sarcoma	0.000671	0.00144	CcSEcCtD
Glipizide—Anxiety—Epirubicin—sarcoma	0.000669	0.00144	CcSEcCtD
Glipizide—Discomfort—Epirubicin—sarcoma	0.000663	0.00143	CcSEcCtD
Glipizide—Malaise—Doxorubicin—sarcoma	0.000658	0.00142	CcSEcCtD
Glipizide—Vertigo—Doxorubicin—sarcoma	0.000655	0.00141	CcSEcCtD
Glipizide—Syncope—Doxorubicin—sarcoma	0.000654	0.00141	CcSEcCtD
Glipizide—Leukopenia—Doxorubicin—sarcoma	0.000653	0.0014	CcSEcCtD
Glipizide—Confusional state—Epirubicin—sarcoma	0.000649	0.0014	CcSEcCtD
Glipizide—Oedema—Epirubicin—sarcoma	0.000643	0.00138	CcSEcCtD
Glipizide—Loss of consciousness—Doxorubicin—sarcoma	0.000641	0.00138	CcSEcCtD
Glipizide—Shock—Epirubicin—sarcoma	0.000633	0.00136	CcSEcCtD
Glipizide—Thrombocytopenia—Epirubicin—sarcoma	0.00063	0.00136	CcSEcCtD
Glipizide—Hypertension—Doxorubicin—sarcoma	0.00063	0.00136	CcSEcCtD
Glipizide—Hyperhidrosis—Epirubicin—sarcoma	0.000622	0.00134	CcSEcCtD
Glipizide—Myalgia—Doxorubicin—sarcoma	0.000621	0.00134	CcSEcCtD
Glipizide—Arthralgia—Doxorubicin—sarcoma	0.000621	0.00134	CcSEcCtD
Glipizide—Anxiety—Doxorubicin—sarcoma	0.000619	0.00133	CcSEcCtD
Glipizide—Discomfort—Doxorubicin—sarcoma	0.000614	0.00132	CcSEcCtD
Glipizide—Anorexia—Epirubicin—sarcoma	0.000613	0.00132	CcSEcCtD
Glipizide—Confusional state—Doxorubicin—sarcoma	0.0006	0.00129	CcSEcCtD
Glipizide—Oedema—Doxorubicin—sarcoma	0.000595	0.00128	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000586	0.00126	CcSEcCtD
Glipizide—Shock—Doxorubicin—sarcoma	0.000586	0.00126	CcSEcCtD
Glipizide—Thrombocytopenia—Doxorubicin—sarcoma	0.000583	0.00125	CcSEcCtD
Glipizide—Insomnia—Epirubicin—sarcoma	0.000582	0.00125	CcSEcCtD
Glipizide—Paraesthesia—Epirubicin—sarcoma	0.000578	0.00124	CcSEcCtD
Glipizide—Hyperhidrosis—Doxorubicin—sarcoma	0.000575	0.00124	CcSEcCtD
Glipizide—Dyspnoea—Epirubicin—sarcoma	0.000574	0.00123	CcSEcCtD
Glipizide—Somnolence—Epirubicin—sarcoma	0.000572	0.00123	CcSEcCtD
Glipizide—Anorexia—Doxorubicin—sarcoma	0.000567	0.00122	CcSEcCtD
Glipizide—Dyspepsia—Epirubicin—sarcoma	0.000566	0.00122	CcSEcCtD
Glipizide—Decreased appetite—Epirubicin—sarcoma	0.000559	0.0012	CcSEcCtD
Glipizide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000555	0.0012	CcSEcCtD
Glipizide—Constipation—Epirubicin—sarcoma	0.00055	0.00118	CcSEcCtD
Glipizide—Pain—Epirubicin—sarcoma	0.00055	0.00118	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000542	0.00117	CcSEcCtD
Glipizide—Insomnia—Doxorubicin—sarcoma	0.000538	0.00116	CcSEcCtD
Glipizide—Paraesthesia—Doxorubicin—sarcoma	0.000535	0.00115	CcSEcCtD
Glipizide—Dyspnoea—Doxorubicin—sarcoma	0.000531	0.00114	CcSEcCtD
Glipizide—Feeling abnormal—Epirubicin—sarcoma	0.00053	0.00114	CcSEcCtD
Glipizide—Somnolence—Doxorubicin—sarcoma	0.000529	0.00114	CcSEcCtD
Glipizide—Gastrointestinal pain—Epirubicin—sarcoma	0.000526	0.00113	CcSEcCtD
Glipizide—Dyspepsia—Doxorubicin—sarcoma	0.000524	0.00113	CcSEcCtD
Glipizide—Decreased appetite—Doxorubicin—sarcoma	0.000517	0.00111	CcSEcCtD
Glipizide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000514	0.00111	CcSEcCtD
Glipizide—Urticaria—Epirubicin—sarcoma	0.000511	0.0011	CcSEcCtD
Glipizide—Constipation—Doxorubicin—sarcoma	0.000509	0.0011	CcSEcCtD
Glipizide—Pain—Doxorubicin—sarcoma	0.000509	0.0011	CcSEcCtD
Glipizide—Abdominal pain—Epirubicin—sarcoma	0.000509	0.00109	CcSEcCtD
Glipizide—Feeling abnormal—Doxorubicin—sarcoma	0.000491	0.00106	CcSEcCtD
Glipizide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000487	0.00105	CcSEcCtD
Glipizide—Hypersensitivity—Epirubicin—sarcoma	0.000474	0.00102	CcSEcCtD
Glipizide—Urticaria—Doxorubicin—sarcoma	0.000473	0.00102	CcSEcCtD
Glipizide—Abdominal pain—Doxorubicin—sarcoma	0.000471	0.00101	CcSEcCtD
Glipizide—Asthenia—Epirubicin—sarcoma	0.000462	0.000993	CcSEcCtD
Glipizide—Pruritus—Epirubicin—sarcoma	0.000455	0.000979	CcSEcCtD
Glipizide—Diarrhoea—Epirubicin—sarcoma	0.00044	0.000947	CcSEcCtD
Glipizide—Hypersensitivity—Doxorubicin—sarcoma	0.000439	0.000944	CcSEcCtD
Glipizide—Asthenia—Doxorubicin—sarcoma	0.000427	0.000919	CcSEcCtD
Glipizide—Dizziness—Epirubicin—sarcoma	0.000425	0.000915	CcSEcCtD
Glipizide—Pruritus—Doxorubicin—sarcoma	0.000421	0.000906	CcSEcCtD
Glipizide—Vomiting—Epirubicin—sarcoma	0.000409	0.00088	CcSEcCtD
Glipizide—Diarrhoea—Doxorubicin—sarcoma	0.000407	0.000876	CcSEcCtD
Glipizide—Rash—Epirubicin—sarcoma	0.000406	0.000873	CcSEcCtD
Glipizide—Dermatitis—Epirubicin—sarcoma	0.000405	0.000872	CcSEcCtD
Glipizide—Headache—Epirubicin—sarcoma	0.000403	0.000867	CcSEcCtD
Glipizide—Dizziness—Doxorubicin—sarcoma	0.000394	0.000847	CcSEcCtD
Glipizide—Nausea—Epirubicin—sarcoma	0.000382	0.000822	CcSEcCtD
Glipizide—Vomiting—Doxorubicin—sarcoma	0.000378	0.000814	CcSEcCtD
Glipizide—Rash—Doxorubicin—sarcoma	0.000375	0.000808	CcSEcCtD
Glipizide—Dermatitis—Doxorubicin—sarcoma	0.000375	0.000807	CcSEcCtD
Glipizide—Headache—Doxorubicin—sarcoma	0.000373	0.000802	CcSEcCtD
Glipizide—Nausea—Doxorubicin—sarcoma	0.000354	0.000761	CcSEcCtD
